NewsBenzingaAgenus、MSSの既治療進行大腸がん(mCRC)で活動性肝転移を伴わない患者を対象にボテンシリマブとバルスチリマブの併用を評価した第1b相C-800-01試験の長期生存者解析から新たな知見を発表 Agenus、MSSの既治療進行大腸がん(mCRC)で活動性肝転移を伴わない患者を対象にボテンシリマブとバルスチリマブの併用を評価した第1b相C-800-01試験の長期生存者解析から新たな知見を発表 Benzinga 2026.11.06 14:04 (GMT+0) Open on Benzinga Other news Is Wall Street Bullish or Bearish on Zimmer Biomet Stock? Clorox Stock Outlook: Is Wall Street Bullish or Bearish? Shorting ConocoPhillips Puts and Put Credit Spreads Are Attractive Income Plays Trump Administration Shrugs Off Big Tech Warnings, Advances Plan to Restrict Chinese Data Center Gear Despite Compliance Woes: Report How To Earn $500 A Month From Target Stock Ahead Of Q3 Earnings Stifel Reinstates Buy on Walmart, Announces $145 Price Target
Trump Administration Shrugs Off Big Tech Warnings, Advances Plan to Restrict Chinese Data Center Gear Despite Compliance Woes: Report